Several countries in Asia are set to see the availability of additional vaccines for the prevention of some of the most common bacterial diseases in the region, by way of an alliance between a new European venture and a Cuban scientific research institute.

New French biotech Abivax is tapping into Cuba’s vaccine expertise in hopes of becoming a leader in the field, initially targeting Asia with its lead hepatitis B jab, which it says offers the potential to cure the disease.

New French biotech Abivax is tapping into Cuba’s vaccine expertise in hopes of becoming a leader in the field, initially targeting Asia with its lead Hepatitis B jab, which it says offers the potential to cure the disease.

Each month, Start-Up presents a survey of technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.